Treatment of endometriosis in the presence of varicose disease
- Authors: Baskakov V.P.1,2, Zazerskaya I.E.1,2, Dyachuk A.V.1,2, Molodykh A.S.1,2, Gavrish N.A.1,2, Shuliko L.A.1,2, Solomko D.V.1,2
-
Affiliations:
- Dr. Sokolov Hospital 122
- I. P. Pavlov State Medical University
- Issue: Vol 48, No 5S (1999)
- Pages: 39-39
- Section: Articles
- Submitted: 15.02.2022
- Accepted: 15.02.2022
- Published: 15.12.1999
- URL: https://journals.eco-vector.com/jowd/article/view/100797
- DOI: https://doi.org/10.17816/JOWD100797
- ID: 100797
Cite item
Full Text
Abstract
Complicity of the situation is stipulated by the fact that the overwhelming majority of drugs used for endometriosis treatment cause a shift in the clotting system towards hypercoagulation. Releasing gonadotropines, first of all Zoladex and Decomeptyl-Depo, present an exception to the rule.
Keywords
Full Text
Complicity of the situation is stipulated by the fact that the overwhelming majority of drugs used for endometriosis treatment cause a shift in the clotting system towards hypercoagulation. Releasing gonadotropines, first of all Zoladex and Decomeptyl-Depo, present an exception to the rule. That is why in order to get the rheologic and clotting blood properties normalized, it is expedient in a process of treating endometriosis to give Trental 0.1 2 to 3 times a day, antioxidants, and apply bandages with anticoagulation cremes. Hyrodotherapy [treatment with leaches] vaginally is indicated for pelvic phlebitis. Besides, Detralex and Madecassor, angioprotectors toning the veins up may be given per os. Other components of this complex therapy (hormones, immunomodulators, antioxidants and so on) are administered as usual. Perspective of surgical treatment necessitates prevention of thromboembolic complications to be carried out through giving heparin, indirect anticoagulants, and early patient ambulation in the postoperative period.
About the authors
V. P. Baskakov
Dr. Sokolov Hospital 122; I. P. Pavlov State Medical University
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg
I. E. Zazerskaya
Dr. Sokolov Hospital 122; I. P. Pavlov State Medical University
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg
A. V. Dyachuk
Dr. Sokolov Hospital 122; I. P. Pavlov State Medical University
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg
A. S. Molodykh
Dr. Sokolov Hospital 122; I. P. Pavlov State Medical University
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg
N. A. Gavrish
Dr. Sokolov Hospital 122; I. P. Pavlov State Medical University
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg
L. A. Shuliko
Dr. Sokolov Hospital 122; I. P. Pavlov State Medical University
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg
D. V. Solomko
Dr. Sokolov Hospital 122; I. P. Pavlov State Medical University
Email: info@eco-vector.com
Russian Federation, St. Petersburg; St. Petersburg